Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03206112 · ClinicalTrials.gov registry record

Loss of Depotentiation in Focal Dystonia

A clinical trial, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

Terminated
Registry status
6
Enrollment target

NCT03206112 is a clinical trial that was terminated before completion, run by National Institute of Neurological Disorders and Stroke (NINDS). The registered enrollment target is 6 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03206112 was terminated before completion, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

TERMINATED
Registry status
6 participants
Enrollment target

Study Summary

Background Focal dystonia is a brain disorder. It affects a muscle or muscles in a specific part of the body. Researchers think it may be related to excessive training or practice. They want to know more about how much training might trigger focal dystonia. Objectives: To study why people develop focal dystonia. To study how brain plasticity changes with focal dystonia. Eligibility: People at least 18 years of age with focal dystonia. Healthy volunteers the same age are also needed. Design: Participants will be screened with a physical exam and questions. They may have blood and urine tests. Participants will have up to 3 testing visits. Participants will have small electrodes stuck on the skin on the hands or arms. Muscle activity will be recorded. Participants will have transcranial magnetic stimulation (TMS). A wire coil will be placed onto the scalp. A brief electrical current will pass through the coil. The current will create a magnetic field that affects brain activity. Participants may be asked to tense certain muscles or do simple actions during TMS. A nerve at the wrist will get weak electrical stimulation. The stimulation may be paired with TMS for very short times. Participants will receive repeated magnetic pulses. Participants will receive a total of 150 pulses during a 10-second period. An entire testing visit will last about 3 hours. ...

Interventions

  • OTHER PAS25
  • OTHER PAS10
  • OTHER PAS25-cTBS150

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2017-09-20
Est. Completion 2020-04-09

What the Registry Record Tells You About NCT03206112

The ClinicalTrials.gov registry entry for NCT03206112 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which PAS25 is the first listed.

NCT03206112 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03206112 about?

NCT03206112 is a clinical study titled "Loss of Depotentiation in Focal Dystonia". Background Focal dystonia is a brain disorder. It affects a muscle or muscles in a specific part of the body. Researchers think it may be related to excessive training or practice. They want to know more about how much training might trigger focal dystonia. Objectives: To study why people develop...

What is the current status of trial NCT03206112?

This trial is currently terminated. The enrollment target is 6 participants. The study started on 2017-09-20. Estimated completion is 2020-04-09.

What interventions are being tested in trial NCT03206112?

The interventions under investigation include: PAS25 (OTHER), PAS10 (OTHER), PAS25-cTBS150 (OTHER).

Who is sponsoring clinical trial NCT03206112?

This trial is sponsored by National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.